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Ehlers-Danlos syndrome (EDS) is a rare heterogeneous group of connective tissue disorders. The vascular type (vEDS) is an
autosomal dominant disorder caused by heterozygousmutations in theCOL3A1 gene predisposing to premature arterial, intestinal,
or uterine rupture.We report a case of a 38-year-oldwomanwith a recent diagnosis of vEDS admitted in the EmergencyDepartment
with a suspicion of a pyelonephritis that evolved to a cardiopulmonary arrest. A fatal retroperitoneal hematoma related with a
haemorrhagic dissection of the right renal artery was found after emergency surgery. This case highlights the need to be aware of
the particular characteristics of vEDS, such as a severe vascular complication that can lead to a fatal outcome.
1. Introduction
Ehlers-Danlos syndrome (EDS) is a rare heterogeneous group
of connective tissue disorders [1]. The estimated prevalence
varies between 1/5000 and 1/25000 [1, 2].
The vascular type (vEDS), formerly known as EDS
type IV [3], is an autosomal dominant disorder caused by
heterozygous mutations in the COL3A1 [4]. Vascular EDS
compromises 5–10% of all cases of EDS [4, 5]. The clinical
hallmark of vEDS is excessive tissue fragility predisposing
to premature arterial, intestinal, or uterine rupture, rarely
observed in other forms of EDS [4, 6]. vEDS is also marked
clinically by a characteristic facial appearance with decreased
subcutaneous fat, a narrow nose, and thin lips and thin
skin with visible superficial veins and prominent cutaneous
bruising. Patients can also present premature aging of dis-
tal extremities (acrogeria) and joint hypermobility [5, 7].
However, these phenotype characteristics can be subtle and
may not be diagnosed until postmortem examination [4, 5].
Furthermore, the natural course of vEDS and the clinical
phenotype of patients are influenced by the type of COL3A1
variant [8].
A full differential diagnosis must be considered when
the presenting signs and symptoms suggest vEDS. This
includesMarfan syndrome, Loeys-Dietz syndrome, kyphosco-
liotic types of EDS, idiopathic isolated arterial aneurysms,
and autosomal dominant polycystic kidney disease. Clinical
features, radiologic findings, and genetic characterization
allow the clinical diagnosis and management [9–11].
Approximately 25% of patients with the vEDS experience
the first complication by the age of 20, while 80% of patients
have at least one complication by the age of 40 [6]. The
median survival described in literature varies between 48 and
50 years [4, 6].
Treatment of complications associated with vEDS favours
minimal noninvasive interventions. Invasivemethods should
be used only when necessary, primarily to save the patients’
life [12].
We report a case of a 38-year-old woman with vEDS,
who died during emergency surgery due to a severe vascular
complication.
2. Case Presentation
A 38-year-old woman was admitted in the Emergency
Department (ED) with a sudden onset of severe lower back
pain, fever, nausea, and vomiting.The patient had a history of
Hindawi Publishing Corporation
Case Reports in Critical Care
Volume 2015, Article ID 804252, 4 pages
http://dx.doi.org/10.1155/2015/804252
2 Case Reports in Critical Care
Figure 1: Abdominal Computer Tomography (CT) scan showing
diffuse reduction in the parenchymal thickness of the right kidney
and multiloculated fluid collection of about 10 centimetres (cm),
involving the anterior part and the upper pole of the right kidney
and the ipsilateral renal artery.
repeated urinary infections and renal lithiasis. She was being
studied in the genetic department because of her history of
infertility and spontaneous abortions and also because of the
history of sudden deaths in her family (including her father).
Therefore, she was diagnosed recently as having vEDS with
a mutation in COLA31 gene, but the specific defect was not
mentioned in her genetic report.
On admission, her physical examination revealed translu-
cid skin, thinned nose, and joint hypermobility of the lower
limbs.
She had haemoglobin (Hg) of 13 g/dL, leukocytosis (16
× 109/L), an elevated C-reactive protein (54mg/dL), and
inactive urinary sediment.
The renal ultrasound showed perirenal fluid and signs of
nephritis but without obstruction.
The Abdominal Computer Tomography (CT) scan
(Figure 1) showed a diffuse reduction in the parenchymal
thickness of the right kidney and multiple areas of striatum
nephrogram, suggesting an inflammatory/infectious process
(pyelonephritis). It also showed a multiloculated fluid
collection of about 10 centimetres (cm), involving the
anterior part and the upper pole of the right kidney and the
ipsilateral renal artery, which appeared tapered and with a
reduced calibre.
In between several exams, she was found unconscious
in the clinical observation area of the ED and was taken to
the Emergency Room (ER) in pulmonary arrest that rapidly
evolved to cardiac arrest, from which she recovered with
advanced life support in 10 minutes.
After initial stabilization in the ER, it was assumed that
this clinical situation was due to a renal abscess, as shown in
CT scan. A renal abscess drainage in the operating room was
immediately proposed for her.
On arrival to the OR, she presented again in cardiopul-
monary arrest in a nonshockable rhythm (pulseless electrical
activity). Advanced life support (ALS) was started immedi-
ately.
The decision to perform an exploratory laparotomy, while
in ALS manoeuvres, was taken and a team of vascular and
urologic surgeons started together the procedure.
During surgery, a massive retroperitoneal hematoma
was found, being largest at the left side. The infrarenal
aorta was isolated but was found pulseless and empty. With
the clamping of the supra- and infrarenal aorta no active
haemorrhage was identified.
ALS manoeuvres were stopped 30 minutes after the
beginning of surgery in the light of these findings and lack
of any clinical response to massive transfusion measures.
Request for a clinical autopsy was obtained.
Autopsy Findings. The victim was a normally developed 38-
year-old woman with apparent age superior to her real age.
The skin of her knees was flaccid and pigmented and she had
an articular hypermobility.
Internal findings included a hematoma in the top and
posterior face of the right kidney which extended until the
exterior of the renal capsule.Thereweremultiple thrombosed
renal vessels of medium and large calibre in the renal
hilum, some of which presented a haemorrhagic dissection
between the intimal andmedia arterial walls, sometimes with
thrombosed pseudo lumens.
In all vascular territories the arterial walls presented
morphological alterations of the intimal and media layers,
namely, duplication and disruption of the internal elastic
lamina, intimal nodular proliferation, and a media layer with
thickening and thinning areas.
In These characteristics were suggestive of intimal and
media fibromuscular dysplasia.
3. Discussion
Vascular EDS is a very challenging disorder. Therefore,
it is important to suspect a severe vascular complication
in a patient with a history of vEDS that presents in the
ED with unspecific symptoms. These patients should be
investigated promptly to rule out life-threatening situations
due to vascular complications involving the vascular system,
gastrointestinal tract, or gravid uterus [2, 6]. The vascular
type of EDS describes a defect in the synthesis of type
III procollagen and is the most severe form. Rupture of
a previously nondilated artery is a common occurrence
that results in considerable mortality and morbidity. Less
commonly, an artery can dissect or dilate in either focal or
diffuse form.
Therefore, patients with vEDS have a reduced life
expectancy due to severe vascular complications. In a series
of 31 patients, 61% present with at least one life-threatening
vascular complication before the age of 40 [13].
An acute low back/flank pain is a common complaint
in young adult presented to the ED and is usually due to a
musculoskeletal or genitourinary tract cause. In our patient
the exams showed an inflammatory/infectious process which
was a likely diagnosis according to her past medical history
of renal lithiasis. However, her recent diagnosis of vEDS was
initially neglected and only because of a rapid hemodynamic
deterioration was a surgical approach decided. There was
a lack of communication among the medical staff, as the
doctors responsible for the patient in the ED did not find
her past medical history of vEDS important for this situation
and this was not transmitted to the doctor responsible for
the Emergency Room (ER) or to the radiologist responsible
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for the report of her abdominal CT scan. It is extremely
important for radiologists to know if the patient has a collagen
vascular disease when ordering the exam. There has to be
more awareness about this syndrome among doctors and
health staff working on the ED so that such situations can
be minimized and a suspicious attitude could be adopted by
every personnel that takes care of patients with vEDS. We
have to remember that the incidence of this disease is very low
(5% of all EDS patients) whichmeans that most surgeons will
never, or perhaps only once, meet a patient with the disease
[12].
Patients with vEDS have unpredictable clinical courses
and management is always challenging as they have high
operative mortality rates. Therefore, we will never know if
the course of our patient would have been different if a more
suspicious attitude took place and all of the team responsible
for the patient knew the disease and the complications
involved. Nevertheless, we have to be aware of a severe
vascular complication when receiving a vEDS patient in the
ED.
A disease specific passport would be very helpful in these
kinds of diseases where severe complications could be present
and special attention and care are needed when these patients
are in the ED. In the case reported, it would have been very
helpful and could have alerted the physicians to have a more
careful approach in patient’s evaluation and care.
The autopsy revealed a retroperitoneal hematoma related
with a haemorrhagic dissection of the right renal artery. This
was probably due to the vascular malformation of fibromus-
cular dysplasia type. Although fibromuscular dysplasia is a
different entity, patients with vEDSmay have stenosis of renal
and visceral arteries that mimic fibromuscular dysplasia. The
diagnosis of these conditions relies on associated phenotypic
traits and genetic tests: acrogeric dysmorphy, distal joint
laxity, and tiny skin elasticity in vEDS, confirmedby detection
of COL3A1 gene mutations [14].
Regarding the treatment in vEDS, the most recent lit-
erature points to a rate of 29% mortality due to open and
endovascular procedures less than the rates published in
older studies [12, 13]. All invasive procedures should be
avoided as far as possible as surgery can lead to vascular
catastrophes and even death [13, 15]. A conservative approach
or minimal invasive procedures should be preferred in these
cases. Furthermore, the excessive rate of arterial complica-
tions in the past in endovascular procedures is believed to be
related to large-diameter sheaths and devices used in prior
decades. However, the prognosis after treatment is poor and
invasivemethods should be used only when necessary to save
the patient’s life [12].
There is no validated medical therapy in primary pre-
vention of cardiovascular events in presymptomatic vEDS
patients.The onlymedical therapy available is celiprolol, a 𝛽1-
adrenoreceptor antagonist with a 𝛽2-adrenoreceptor agonist
action. The only multicenter randomized trial by Ong et al.,
2010, showed an effective prevention of major complications
in patients with vEDS, with a reduction in arterial events
(rupture or dissection) by three times compared with no
treatment.Nevertheless, there is no indication that the benefit
of celiprolol is a class effect and the question of beta blocker
treatment remains open [16].
In summary, vEDS is associated with severe vascular
complications in relatively young patients. We presented a
case of a patient with vEDS with a fatal outcome and a
misleading diagnosis after a spontaneous dissection of the
renal artery.
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